Agreed. As one could expect, TLX has become a much more stable and well-behaved stock since 2024, compared to previous years.
A solid revenue stream + beating estimates + ASX100 approaching on the horizon + TLX591 positive data + a better understanding of TLX by the market + a great momentum for precision radiation and biotech, etc... certainly helped a lot!
Ann: ProstACT SELECT Study of TLX591 rADC Therapy - Positive rPFS, page-173
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.14 |
Change
0.190(1.06%) |
Mkt cap ! $6.061B | |||
| Open | High | Low | Value | Volume |
| $17.98 | $18.17 | $17.67 | $21.23M | 1.181M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2565 | $18.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.14 | 1977 | 2 |
View Market Depth
| Last trade - 16.10pm 20/06/2024 (20 minute delay) ? |
| TLX (ASX) Chart |